edaravone

XGen Pharmaceuticals DJB, Inc.🇺🇸 United States

FDA Page

Effective Date: May 28, 2026
Approval ID: a8245a98-2ccb-4062-b865-3aa348351b48
Products: 2 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EDARAVONE INJECTION safely and effectively. See full prescribing information for EDARAVONE INJECTION. EDARAVONE injection, for intravenous use Initial U.S. Approval: 2017

Quick Stats

Total Products2

Labelers2

Label Sections30

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.